83 related articles for article (PubMed ID: 20109880)
1. Lung cancer and hormone replacement therapy.
Grant EC
Lancet; 2010 Jan; 375(9709):117; author reply 118-9. PubMed ID: 20109880
[No Abstract] [Full Text] [Related]
2. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
3. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
4. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
Purmonen S; Manninen T; Pennanen P; Ylikomi T
Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy in menopause and lung cancer: an update.
La Vecchia C
Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859
[No Abstract] [Full Text] [Related]
6. Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor alpha and c-Myc.
Dadiani M; Seger D; Kreizman T; Badikhi D; Margalit R; Eilam R; Degani H
Endocr Relat Cancer; 2009 Sep; 16(3):819-34. PubMed ID: 19398483
[TBL] [Abstract][Full Text] [Related]
7. Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.
Hyder SM; Liang Y; Wu J; Welbern V
Endocr Relat Cancer; 2009 Sep; 16(3):809-17. PubMed ID: 19570906
[TBL] [Abstract][Full Text] [Related]
8. Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer.
Farhat FS; Tfayli A; Fakhruddin N; Mahfouz R; Otrock ZK; Alameddine RS; Awada AH; Shamseddine A
Crit Rev Oncol Hematol; 2012 Nov; 84(2):149-60. PubMed ID: 22494932
[TBL] [Abstract][Full Text] [Related]
9. Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells.
Mafuvadze B; Benakanakere I; Hyder SM
Menopause; 2010; 17(5):1055-63. PubMed ID: 20551847
[TBL] [Abstract][Full Text] [Related]
10. MYC-microRNA-9-metastasis connection in breast cancer.
Almeida MI; Reis RM; Calin GA
Cell Res; 2010 Jun; 20(6):603-4. PubMed ID: 20502442
[No Abstract] [Full Text] [Related]
11. Progesterone, progestins, pregnancy and breast cancer risk.
Ferretti G
Breast Cancer Res Treat; 2007 Jul; 103(3):373-4. PubMed ID: 17063269
[No Abstract] [Full Text] [Related]
12. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S
Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449
[TBL] [Abstract][Full Text] [Related]
13. The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines.
Kee NL; Naudé RJ; Blatch GL; Frost CL
Biol Chem; 2012 Mar; 393(3):113-21. PubMed ID: 22718627
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer and hormone replacement therapy.
Barton M; Meyer MR; Bolton JL; Prossnitz ER
Lancet; 2010 Jan; 375(9709):117-8; author reply 118-9. PubMed ID: 20109881
[No Abstract] [Full Text] [Related]
15. Hormone therapy and endometrial angiogenesis.
Mirkin S; Navarro F; Archer DF
Climacteric; 2003 Dec; 6(4):273-7. PubMed ID: 15006248
[TBL] [Abstract][Full Text] [Related]
16. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
[TBL] [Abstract][Full Text] [Related]
17. [MT1-MMP up-regulates VEGF expression in human breast carcinoma MCF-7 cells and induces tumor angiogenesis].
Deng YP; Li W; Li YL; Xu H; Liang SS; Zhang LH; Li YL
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):727-31. PubMed ID: 20021822
[TBL] [Abstract][Full Text] [Related]
18. The role of vascular endothelial growth factor a polymorphisms in breast cancer.
Sa-Nguanraksa D; O-Charoenrat P
Int J Mol Sci; 2012 Nov; 13(11):14845-64. PubMed ID: 23203097
[TBL] [Abstract][Full Text] [Related]
19. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
20. [Meta-analysis of the effects on hormone replacement therapy and oral contraceptives associated with female lung cancer risk].
Chen X; Cai L
Wei Sheng Yan Jiu; 2009 Nov; 38(6):672-6. PubMed ID: 20047219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
